BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Translational Resource Center - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Translational Resource Center
X-ORIGINAL-URL:https://translationalresourcecenter.org
X-WR-CALDESC:Events for Translational Resource Center
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20220113T113000
DTEND;TZID=UTC:20220113T123000
DTSTAMP:20211112T014005Z
CREATED:20211112T014005Z
LAST-MODIFIED:20211112T014005Z
UID:3028-1642073400-1642077000@translationalresourcecenter.org
SUMMARY:Bench2Market Talk: FDA Regulatory Strategy
DESCRIPTION:Join us on January 13\, 2022 for a discussion about regulatory pathways\, options and timing. \nStay Tuned! More to come! \nBench2Market Talks are: \n\nDesigned for entrepreneurs in the university life science research community\nProvides tools to communicate the commercial potential of your research\nTopics\, presentations and lectures relevant to technology translation
URL:https://translationalresourcecenter.org/event/bench2market-fda-regulatory-strategy/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220108
DTEND;VALUE=DATE:20220111
DTSTAMP:20210624T193009Z
CREATED:20210624T193009Z
LAST-MODIFIED:20210624T193009Z
UID:2770-1641600000-1641859199@translationalresourcecenter.org
SUMMARY:Society for Biomaterials 2022 Joint Symposium
DESCRIPTION:The Society For Biomaterials (US) and the Japanese Society for Biomaterials are hosting a Joint Symposium that will highlight the seminal work of four pioneers in the biomaterials field January 8-10\, 2022 in Honolulu\, Hawaii! \n \nRegistration to open on August 2\, 2021.  See site for meeting details. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe abstract submission deadline is September 1\, 2021 at 11:59 PM EST ($10 submission fee) \nCall for Abstracts (Now Open)\nAbstracts for an oral or poster presentation are being solicited in four general session areas:  \n\n\n\n\n\n\n\n\n\nImplant Pathology & the Foreign Body Reaction\nPolymeric Biomaterials\nBioglasses / Ceramics\nTissue Engineering\n\n\n\n\n\n\nAdditional information on the scope of each general session and symposium is available on the\n2022 Hawaii – Joint Symposium – SFB + JSB web site: https://biomaterials.org/2022-abstracts \nSimply visit the 2022 Hawaii – Joint Symposium web site at https://biomaterials.org/events-future-meetings/2022-hawaii-joint-symposium-sfb-jsb where you will find information on abstract submissions. \nPlease contact the Society For Biomaterials headquarters office with any questions or concerns. \nThank you for your continued support of the Society For Biomaterials and the Japanese Society for Biomaterials!
URL:https://translationalresourcecenter.org/event/society-for-biomaterials-joint-symposium-2022/
LOCATION:Hilton Waikiki Beach\, Honolulu\, Hawaii
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211215T100000
DTEND;TZID=UTC:20211215T153000
DTSTAMP:20211102T191445Z
CREATED:20211102T191445Z
LAST-MODIFIED:20211102T191445Z
UID:3013-1639562400-1639582200@translationalresourcecenter.org
SUMMARY:DOD Proposal Development
DESCRIPTION:This Dept. of Defense-focused workshop provides detailed instruction on preparing a proposal to meet the requirements of the DOD\, including both technical and commercialization plans\, and navigating the submission process.\nPresented by DOD SBIR/STTR expert\, Monique Branham\, the program will also cover: \n\nSBIR/STTR program basics and up-to-date information on the DoD program\nAn understanding of the differences between DoD components\nTips on how to identify a topic\nThe importance of talking to Technical Points of Contact during the pre-release period\nWriting to meet the reviewers’ expectations\nCommon pitfalls and how to avoid them\, and more!\n\nTo register and to learn more about the speaker for this event\, go here. (Please note that there is a cost to attend this event.) \n(SHARPhub companies should register at sharpideahub.com) \nAbout BBC Entrepreneurial Training & Consulting\nBBCetc is nationally recognized for its success in helping emerging companies win SBIR/STTR funding and use it strategically to propel growth. BBCetc’s Michigan clients have been awarded over $350 million in funding since 2002. The company was recently named a 2020 Tibbetts award winner as well as one of 50 “Michigan companies to watch” by Michigan Celebrates Small Business. \n(Time listed is Eastern Standard Time)
URL:https://translationalresourcecenter.org/event/dod-proposal-development/
LOCATION:Virtual
CATEGORIES:Events,Featured Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211214
DTEND;VALUE=DATE:20211218
DTSTAMP:20211007T165426Z
CREATED:20211007T165426Z
LAST-MODIFIED:20211007T165426Z
UID:2964-1639440000-1639785599@translationalresourcecenter.org
SUMMARY:Derivation and Culture of Human Induced Pluripotent Stem Cells (hiPSCs) (Virtual)
DESCRIPTION:Please note: Due to the ongoing situation with Covid-19\, this course will be delivered in a virtual format. \nThis popular course was stablished in 2015 in collaboration with the Wellcome Sanger Institute Cellular Generation and Phenotyping (CGaP) core facility and the UK Stem Cell Bank. \nThis year’s 4-day virtual course includes virtual\, laboratory-based training sessions\, lectures\, and discussions covering current theory and best practices with regard to derivation\, culture and characterization of human induced pluripotent stem cells (hiPSCs). \nTarget Audience\nThe course is aimed at research scientists and clinicians/healthcare professionals engaged in relevant research involving hiPSCs. \nLearning outcomes\nAfter attending this course\, participants should be able to: \n\nAssess and identify key advantages\, disadvantages and critical elements of different approaches to somatic cell reprogramming\nAssess and identify undifferentiated\, fully reprogrammed iPSCs compared to partially reprogrammed iPSC colonies\nRecognize critical aspects for successful preservation and storage\nEvaluate the recovery of iPSCs and identify viable cells\nIdentify undifferentiated morphology of confluent iPSCs ready for passaging\nIdentify and troubleshoot critical aspects in the passaging and maintenance of undifferentiated iPSCs\nRecognize the importance of core QC and potential consequences of failing to carry it out\nEvaluate different capabilities of each method of determining potential pluripotency\n\nVisit the main page for more information and to register for this course.
URL:https://translationalresourcecenter.org/event/derivation-and-culture-of-human-induced-pluripotent-stem-cells-hipscs-virtual/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211209T120000
DTEND;TZID=UTC:20211209T133000
DTSTAMP:20211102T191058Z
CREATED:20211102T191058Z
LAST-MODIFIED:20211102T191058Z
UID:3011-1639051200-1639056600@translationalresourcecenter.org
SUMMARY:ABCs of SBIR/STTR Programs
DESCRIPTION:The government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs make over $4 billion in high-risk\, non-dilutive capital available to innovative small companies annually. The process is complex with a steep learning curve\, but the impact of receiving $millions in non-dilutive funding is worth the effort.\nFind out how these two programs can provide a source of R&D funding between the initial development of your innovative idea and proof that it has potential in the marketplace. We’ll cover SBIR/STTR eligibility requirements\, participating agencies\, the differences between SBIR and STTR and more! \nThis training is designed to provide enough information for attendees to determine if they would like to seriously pursue proposal development and provides the tools to help begin the process. \nTo register for this event\, go here. \nTraining Sponsored by BBCetc Catalyst Advantage Network\nBBCetc Catalyst Advantage Network (C.A.N.) provides the benefit of BBCetc’s SBIR/STTR expertise along with Capita3’s leadership training to give women entrepreneurs what’s needed to successfully transform your technology into a viable product or service and secure government funding. Learn more here. \n(Time listed is Eastern Standard Time)
URL:https://translationalresourcecenter.org/event/abcs-of-sbir-sttr-programs/
LOCATION:Virtual
CATEGORIES:Events,Featured Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211208T120000
DTEND;TZID=UTC:20211208T130000
DTSTAMP:20211201T231321Z
CREATED:20211201T231321Z
LAST-MODIFIED:20211201T231321Z
UID:3058-1638964800-1638968400@translationalresourcecenter.org
SUMMARY:Science Webinar/AAAS presents: Enabling the transition between research and clinical medicine in oncology
DESCRIPTION:Overview\nThe translation of bench research into the clinical environment has accelerated significantly in recent years\, and the need for clinically validated workflows has never been stronger. This webinar takes a closer look at this need\, particularly in the oncology space\, and discusses what the future for workflow validation might be. The considerable knowledge built up over years—and especially during the recent COVID-19 pandemic—is relevant to many disease states and can be applied universally\, ensuring that globally standardized\, scalable technologies can realize their full clinical potential. \nThe discussion will include: \n\nThe latest developments in integrated diagnostics and patient profiling\, combining molecular and proteomics workflows\nThe urgent need for translational research of biomarkers that have clinical relevance for optimizing diagnosis and treatment plans\nThe challenges of translating new techniques—such as liquid biopsies—into regulated\, scalable methodologies that will drive future global diagnostics and therapeutics\nThe importance of building firm foundations in robust and reproducible research technologies\, democratization of automated workflows\, and digital connectivity of data.\n\n\nPresenters\n\n\n\n\n\n\n\nSpeaker: Achim von Leoprechting\, Ph.D.\nTecan\nMännedorf\, Switzerland \n\n\n\n\n\n\n\nSpeaker: Stephen Harding\, Ph.D.\nThe Binding Site\nBirmingham\, UK \n\n\n\n\n\n\n\nModerator: Sean Sanders\, Ph.D.\nScience/AAAS\nWashington\, DC\n\nFor more information and to register for this free webinar\, go here.\n\n\n\n\nThis webinar will take place on Wednesday\, December 8\, 2021 at 12:00pm Eastern (9 a.m. Pacific\, 5 p.m. UK (GMT)\, 6 p.m. Central Europe (CET))
URL:https://translationalresourcecenter.org/event/science-webinar-aaas-presents-enabling-the-transition-between-research-and-clinical-medicine-in-oncology/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211208T113000
DTEND;TZID=UTC:20211208T123000
DTSTAMP:20211112T013523Z
CREATED:20211112T013523Z
LAST-MODIFIED:20211112T013523Z
UID:3027-1638963000-1638966600@translationalresourcecenter.org
SUMMARY:Bench2Market Talk: IP Strategy
DESCRIPTION:Join us on December 8\, 2021 for a discussion about patentability\, freedom to operate\, prior art and patent strategies. \nStay tuned! More details to come! \nBench2Market Talks are: \n\nDesigned for entrepreneurs in the university life science research community\nProvides tools to communicate the commercial potential of your research\nTopics\, presentations and lectures relevant to technology translation
URL:https://translationalresourcecenter.org/event/bench2market-talk-ip-strategy/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211206T110000
DTEND;TZID=UTC:20211207T150000
DTSTAMP:20211102T170257Z
CREATED:20211102T170257Z
LAST-MODIFIED:20211102T170257Z
UID:2991-1638788400-1638889200@translationalresourcecenter.org
SUMMARY:2021 DOCTRC Retreat: December 6-7\, 2021
DESCRIPTION:Welcome to the 2nd Annual Joint DOCTRC Retreat cohosted by: C-DOCTOR & MPWRM Resource Center!\nThe DOCTRC Annual Joint Retreat will be held virtually on December 6-7\, 2021. This meeting will showcase progress of Interdisciplinary Translational Project (ITP) teams supported by C-DOCTOR and the MPWRM Resource Center\, as well as a breakout session “Critical considerations in preclinical product development” and a keynote address from Dr. Lara Ionescu Silverman.  The site will be updated with additional information as the date approaches. \nPlease see this link for the preliminary agenda. \nOn behalf of the DOCTRC leadership\, we look forward to seeing you at the retreat!
URL:https://translationalresourcecenter.org/event/2021-doctrc-retreat-december-6-7-2021/
LOCATION:Virtual
CATEGORIES:Events,Featured Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211122T120000
DTEND;TZID=UTC:20211122T130000
DTSTAMP:20210928T170356Z
CREATED:20210928T170356Z
LAST-MODIFIED:20210928T170356Z
UID:2892-1637582400-1637586000@translationalresourcecenter.org
SUMMARY:USC/CHLA Cell Therapy Program Seminar Series: “Delivering on the Promise of Cell & Gene Therapy”
DESCRIPTION:USC/CHLA Cell Therapy Program Seminar Series\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDon’t miss our November seminar! \n“Delivering on the Promise of Cell & Gene Therapy” \nSpeaker:\nJames (Jay) Bradner\, M.D.\nPresident of the Novartis Institutes for BioMedical Research (NIBR) \nMonday\, November 22\, 2021\n12pm-1pm \nLearn more about: \n\nThe innovation of first CART cell therapy\, and the outlook for stem-progenitor cell therapy in hematology.\nThe design principles for AAV gene therapy\, and learnings from Spinal Muscular Atrophy\nBiological engineering strategies to overcome challenges with next-generation Cell & Gene Therapy\n\nTo register for this webinar\, go here.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n 
URL:https://translationalresourcecenter.org/event/usc-chla-cell-therapy-program-seminar-series-delivering-on-the-promise-of-cell-gene-therapy/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211119T090000
DTEND;TZID=UTC:20211119T110000
DTSTAMP:20211102T183702Z
CREATED:20211102T183702Z
LAST-MODIFIED:20211102T183702Z
UID:3009-1637312400-1637319600@translationalresourcecenter.org
SUMMARY:Commercialization Planning for SBIR/STTR Stage Companies
DESCRIPTION:Commercialization and transition plans can be a key differentiator in the SBIR/STTR programs\, it is important to know what the agencies are looking for and how to go about developing a good plan. This session will review the requirements and guide you through where to start\, what to include\, and how to show your best self. \nWE’LL REVIEW:\n\nAgency expectations for commercialization plans in your Phase I & II projects\nWhere to find cost effective market research\nWhat to include in your finance plan and revenue stream\nWhat quality “support & commitment letters” are and more!\n\nTo register for this event and learn more about the presenter\, go here. (Please note there is a cost to attend this event) \n(SHARPhub companies should register at sharpideahub.com) \nAbout BBC Entrepreneurial Training & Consulting\nBBCetc is nationally recognized for its success in helping emerging companies win SBIR/STTR funding and use it strategically to propel growth. BBCetc’s Michigan clients have been awarded over $330 million in funding since 2002. The company was recently named a 2020 Tibbetts award winner as well as one of 50 “Michigan companies to watch” by Michigan Celebrates Small Business. \n(Time listed is Eastern Standard Time)
URL:https://translationalresourcecenter.org/event/commercialization-planning-for-sbir-sttr-stage-companies/
LOCATION:Virtual
CATEGORIES:Events,Featured Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211117T113000
DTEND;TZID=UTC:20211117T123000
DTSTAMP:20211112T004639Z
CREATED:20211112T004639Z
LAST-MODIFIED:20211112T004639Z
UID:3025-1637148600-1637152200@translationalresourcecenter.org
SUMMARY:Bench2Market Talk: Tales from the Trenches
DESCRIPTION:Join us on November 17th for a panel discussion with Emory University and Georgia Tech faculty sharing their commercialization journey. Learn about their experiences and hurdles to bring their innovations out of academia and into the marketplace. \nRegister here. \nModerator: John Nicosia\, PhD\, Biolocity Associate Director\nSpeakers:\n· James Dahlman\, PhD Associate Professor in the Georgia Tech BME Department\n· Kenny Offermann\, MD\, PhD\, CEO OncoSpherix\n· Yogi Patel\, PhD\, President\, Focused Cryo\n· James Rains Professor of the Practice\, Wallace H. Coulter Department of Biomedical Engineering and Director of BME Capstone \nBench2Market Talks are: \n\nDesigned for entrepreneurs in the university life science research community\nProvides tools to communicate the commercial potential of your research\nTopics\, presentations and lectures relevant to technology translation
URL:https://translationalresourcecenter.org/event/bench2market-talk-tales-from-the-trenches/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211116T120000
DTEND;TZID=UTC:20211116T133000
DTSTAMP:20211102T181700Z
CREATED:20211102T181700Z
LAST-MODIFIED:20211102T181700Z
UID:3006-1637064000-1637069400@translationalresourcecenter.org
SUMMARY:DOD Rebranded Components
DESCRIPTION:Join this virtual training and learn the goals and initiatives of DOD’s rebranded components. We’ll review DOD’s mission and provide an overview of all DOD components. AFWERX\, SPARTN\, SOFWERX\, xTechsearch\, etc… all have different focus\, eligibility requirements and solicitation deadlines. Learn which ones participate in the SBIR/STTR programs\, How the components differ and How to find open BAA’s and deadlines. \nTo register and to learn more about the speaker for this event\, go here. \n(SHARPhub companies should register at sharpideahub.com) \nAbout BBC Entrepreneurial Training & Consulting\nBBCetc is nationally recognized for its success in helping emerging companies win SBIR/STTR funding and use it strategically to propel growth. BBCetc’s Michigan clients have been awarded over $330 million in funding since 2002. The company was recently named a 2020 Tibbetts award winner as well as one of 50 “Michigan companies to watch” by Michigan Celebrates Small Business. \n(Time listed is Eastern Standard Time)
URL:https://translationalresourcecenter.org/event/dod-rebranded-components/
LOCATION:Virtual
CATEGORIES:Events,Featured Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211116T080000
DTEND;TZID=UTC:20211118T173000
DTSTAMP:20211007T165004Z
CREATED:20211007T165004Z
LAST-MODIFIED:20211007T165004Z
UID:2962-1637049600-1637256600@translationalresourcecenter.org
SUMMARY:CRISPR 2.0 Summit
DESCRIPTION:Discover the Next Generation of Precise\, Safe & Effective Gene Editing Approaches \nCRISPR is one of the most powerful discoveries of the last decade\, and we are now heralding in the era of gene editing. \nIn the time since its discovery\, CRISPR has rapidly become an established tool in the genomics toolbox. Now the question is: What next? \nThe CRISPR 2.0 Summit is devoted to showcasing only the latest and greatest innovations by uncovering how the next generation of CRISPR tools are radically enhancing efficacy\, minimizing off-target effects & enabling efficient delivery to specific tissues to ensure you stay at the forefront of this rapidly exploding field. \nDiscover the promise of novel Cas variants\, base and prime editing approaches\, innovative delivery mechanisms\, and the applications of these next generation tools through learnings from CRISPR clinical trials and new & unpublished data. \nDon’t get left behind. Join 100+ leading pharma and biotech companies pioneering CRISPR-based therapeutics into the clinic to usher in the next generation of safe\, targeted and effective genome editing. \nView the event guide now for the full agenda! \nTo register for this event\, go here. \n*There is a cost to attend this event.  See the registration page for more details.*
URL:https://translationalresourcecenter.org/event/crispr-2-0-summit/
LOCATION:AZ
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211116
DTEND;VALUE=DATE:20211119
DTSTAMP:20211007T000505Z
CREATED:20211007T000505Z
LAST-MODIFIED:20211007T000505Z
UID:2959-1637020800-1637279999@translationalresourcecenter.org
SUMMARY:Onco Cell Therapy Summit 2021
DESCRIPTION:WHY ATTEND\nThe world shut down in 2020 as the pandemic had a global impact on trade and development\, but the onco cell therapy industry remained resilient in the face of all of this. In spite of 69% of industry claiming that their biggest challenges in 2020 was meeting their projected timelines for their pipes\, the race for bringing the first BCMA targeting CAR-T to the market is reaching a climax and next-generation cell therapies are at the front of mind for those in both industry and research. \n\n\n\n\nSignificant break throughs in GvHD for allogeneic treatments and in the use of alternative cell therapies mean that onco cell therapies are embedding themselves as the 5th pillar of oncology. New combination studies and manufacturing capabilities are showing even more promise for this sector\, but with current treatments still having high costs of use and as there are limited patient pools\, there are still challenges in both clinical and commercial use of these therapies. \nThe Onco Cell Therapy Summit (OCTS)\, November 16 – 18\, Boston USA\, brings the industry together to share novel research\, manufacturing techniques\, and regulatory best practice. Each session of OCTS 2021 is dedicated to the process of translating R&D into commercially viable oncological therapies. \nWe’ve worked with industry partners to ensure that OCTS 2021 is dedicated to the effective translation and commercialization of research into safe and efficacious therapies and address these challenges. \nSpeaker List\n\n\n \n\nGo here for more information and to register for the event. \n*See the costs on the registration page.*
URL:https://translationalresourcecenter.org/event/onco-cell-therapy-summit-2021/
LOCATION:Boston Park Plaza\, 50 Park Plaza\, Boston\, MA\, 02116\, United States
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211115T080000
DTEND;TZID=UTC:20211119T170000
DTSTAMP:20210803T173141Z
CREATED:20210803T173141Z
LAST-MODIFIED:20210803T173141Z
UID:2809-1636963200-1637341200@translationalresourcecenter.org
SUMMARY:TERMIS 6th World Congress
DESCRIPTION:6th World Congress 2021 \nWe would like to warmly welcome you to the website of the 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS2021). On this website you will find all information necessary to attend the congress that will take place 15 – 19 November 2021 in Maastricht\, the Netherlands. \nMaastricht is at the center of a fervid European region in the field of tissue engineering and regenerative medicine\, encompassing more than 4 centers of excellence\, including Prometheus at KU Leuven\, GIGA\, at the University of Liege\, the Center for Biohybrid Medical Systems at RWTH Aachen\, and the MERLN Institute at Maastricht University. The close vicinity with different incubator campuses allows these centers to also have the required support to translate research to the clinic through the market. \nThe general theme of the congress is “Biologically inspired technology driven regenerative medicine”\, which is fully reflected in the 9 parallel thematic sessions to which you can submit abstracts for oral and poster presentation. The congress program also consists of a number of special sessions\, including national societies sessions\, SYIS sessions\, industrial sessions\, clinical sessions\, European Project sessions\, lunch workshops\, and our usual business plan competition. \nThe congress equally foresees ample opportunities for networking\, including a social dinner\, and a SYIS networking evening for young members. \nThe vibrant city of Maastricht offers the ideal setting for socializing with your colleagues while enjoying the exciting scientific program. The oldest city in the Netherlands\, settled around the 50 B.C.\, Maastricht is the second city for number of National monuments after Amsterdam. Rests of the Roman walls pervade the city. Maastricht is also famous for being the city where the European Community treaty (the Maastricht treaty) has been signed\, which can be visited at the Government palace. The historical neighboring city of Aachen is famous for its cathedral\, which houses the remains of Charlemagne\, and the RWTH Aachen University\, the world’s largest engineering school. Right across the border with Belgium\, in Liège\, you can visit the award-winning moder train station and a bit further north\, you can visit Leuven\, the oldest university city in the Low Countries (Est 1425) and home to the world’s largest brewery company.  Maastricht is at the heart of Europe\, from which Brussels can be reach in 1.5 hours\, Amsterdam in 2 hours\, Paris in 2 hours and half\, and London in 3 hours.
URL:https://translationalresourcecenter.org/event/termis-6th-world-congress/
LOCATION:AZ
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211110T120000
DTEND;TZID=UTC:20211110T133000
DTSTAMP:20211102T180747Z
CREATED:20211102T180747Z
LAST-MODIFIED:20211102T180747Z
UID:3003-1636545600-1636551000@translationalresourcecenter.org
SUMMARY:ABCs of SBIR/STTR
DESCRIPTION:The government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs make over $4 billion in high-risk\, non-dilutive capital available to innovative small companies annually. The process is complex with a steep learning curve\, but the impact of receiving $millions in non-dilutive funding is worth the effort.\nFind out if your technology company is eligible for non-dilutive (FREE) federal funding through the government’s SBIR/STTR program. Join us for this webinar covering SBIR/STTR program basics including program purpose; eligibility; and sources of funding. \nTo register for this event\, go here. \nTraining Sponsored by BBCetc Catalyst Advantage Network\nBBCetc Catalyst Advantage Network (C.A.N.) provides the benefit of BBCetc’s SBIR/STTR expertise along with Capita3’s leadership training to give women entrepreneurs what’s needed to successfully transform your technology into a viable product or service and secure government funding. Learn more here. \n(Time listed is Eastern Standard Time)
URL:https://translationalresourcecenter.org/event/abcs-of-sbir-sttr/
LOCATION:Virtual
CATEGORIES:Events,Featured Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211110T113000
DTEND;TZID=UTC:20211110T130000
DTSTAMP:20211105T164013Z
CREATED:20211105T164013Z
LAST-MODIFIED:20211105T164013Z
UID:3017-1636543800-1636549200@translationalresourcecenter.org
SUMMARY:Developing the Regenerative Medicine Workforce Webinar
DESCRIPTION:You’re invited! The Regenerative Medicine Development Organization and STEM CELLS Translational Medicine are hosting a FREE webinar: \nDeveloping the Regenerative Medicine WorkforceWednesday\, November 10\, from 11:30 am – 1:00 pm EST. \nJoin the discussion as key leaders in the field talk about the skill needs and gaps in regenerative medicine and their implications for practice and policy. This was THE hot topic for our 2021 Virtual World Stem Cell Summit in June. \nDiscussion topics: \n\nCommon employability skills and core bioscience skills\nSurvey of technical skill needs for regenerative medicine\nThe practical impact of skill needs and gaps for faculty and program development\nWorkforce development and the regenerative medicine policy agenda\n\nFeatured Speakers: \n\nRuss Read (Forsyth Community and Technical College)\,\nDr. Gary Green (Wake Forest Institute for Regenerative Medicine)\,\nDr. Linnea Fletcher (InnovATEBIO\, Austin Community College)\,\nDr. James DeKloe (Solano College)\,\nAndrew Briete (VitaCyte\, Inc.)\,\nDr. V. Celeste Carter (NSF\, Advanced Technological Education program)\,\nBernie Siegel (Regenerative Medicine Foundation)\,\nJanet Marchibroda (Alliance for Cell Therapy Now)\n\nWho should attend: \n\nLeaders in regenerative medicine research and manufacturing\nStudents\, faculty\, and heads of university and community college bioscience programs\nSpecialists from biomanufacturing enterprises\nProfessionals in workforce development\n\nRegister here today!
URL:https://translationalresourcecenter.org/event/developing-the-regenerative-medicine-workforce-webinar/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211110T090000
DTEND;TZID=UTC:20211110T150000
DTSTAMP:20211101T191518Z
CREATED:20211101T191518Z
LAST-MODIFIED:20211101T191518Z
UID:2988-1636534800-1636556400@translationalresourcecenter.org
SUMMARY:Robust\, Predictive Alternative Methods for Assessing Biocompatibility of Dental Materials
DESCRIPTION:Information for this workshop is available in this REGISTRATION FORM. Please register by COB November 5th. Connection information and additional details for the workshop will be forthcoming after registration. \nThis workshop will convene key stakeholders from academia\, NIH\, NIST and FDA to discuss major challenges in the biocompatibility assessment of new dental restorative materials during early stages of product development\, explore potential solutions to overcome limitations in predictive preclinical testing and establish opportunities for collaboration in this domain. \nThere has been increasing research in recent years on the development of new approach methodologies (NAMs\, e.g.  in vitro or in chemico assays) that can potentially yield similar results to in vivo testing. The focus of this workshop is on NAMs that could be used to predict the biocompatibility of dental materials. In materials research\, these NAMs could be used to identify biocompatibility related problems earlier in the design process and enable process or material component changes prior to investing significant resources into regulatory procedures. We will also focus on recent work that has been conducted to use quality tools to improve measurement confidence in NAMs.
URL:https://translationalresourcecenter.org/event/robust-predictive-alternative-methods-for-assessing-biocompatibility-of-dental-materials/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211109T200000
DTEND;TZID=UTC:20211109T210000
DTSTAMP:20211109T001715Z
CREATED:20211109T001715Z
LAST-MODIFIED:20211109T001715Z
UID:3020-1636488000-1636491600@translationalresourcecenter.org
SUMMARY:Osteo Science Foundation Webinar Series: Advances in Translational Dentistry: 2021 New Strategies for Dental Tissue Regeneration
DESCRIPTION:ADVANCES IN TRANSLATIONAL DENTISTRY: NEW STRATEGIES FOR DENTAL TISSUE REGENERATION\nEffective methods for the functional repair of craniomaxillofacial (CMF) hard and soft tissue regeneration remain a significant health challenge for both civilians and military personnel. Recent advances in Tissue Engineering and Regenerative Medicine and Dentistry provide promise for new and\nmore effective therapies to repair and regenerate CMF tissues in a timely manner. Here we will discuss some of these recent and exciting approaches and discuss how they are driving the future of clinical dentistry and Oral and Maxillofacial surgical therapies. \nAccreditation\nThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute\, LLC and Osteo Science Foundation. The PeerPoint Medical Education Institute\, LLC is accredited by the ACCME to provide continuing medical education for physicians. \nDesignation\nThe PeerPoint Medical Education Institute\, LLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. 1 CME credit will also be provided. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nOsteo Science Foundation’s mission is to advance hard and soft tissue regeneration\, with a focus on Oral and CranioMaxillofacial Surgery. The Foundation was established by Dr. Peter Geistlich in 2013 and is funded by Geistlich Pharma\, a global leader in regenerative medicine for dental\, oral\, and maxillofacial surgery. Osteo Science Foundation is dedicated to advancing scientific research and education that leads to improved outcomes for patient and operates as an independent\, privately funded 501(c)(3) non-profit organization. For more information\, please visit www.osteoscience.org \nTo register for this complimentary program\, visit www.osteoscience.org
URL:https://translationalresourcecenter.org/event/osteo-science-foundation-webinar-series-advances-in-translational-dentistry-2021-new-strategies-for-dental-tissue-regeneration/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211108
DTSTAMP:20200213T235048Z
CREATED:20200213T235048Z
LAST-MODIFIED:20200213T235048Z
UID:2416-1635984000-1636329599@translationalresourcecenter.org
SUMMARY:American Academy of Periodontology 107th Annual Meeting
DESCRIPTION:Mark your calendars for the American Academy of Periodontology 107th Annual Meeting being held November 4-7\, 2021!
URL:https://translationalresourcecenter.org/event/american-academy-of-periodontology-107th-annual-meeting/
LOCATION:Miami Beach Convention Center\, Miami\, Florida
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211102T080000
DTEND;TZID=UTC:20211104T170000
DTSTAMP:20210125T172021Z
CREATED:20210125T172021Z
LAST-MODIFIED:20210125T172021Z
UID:2656-1635840000-1636045200@translationalresourcecenter.org
SUMMARY:A Time That's Come: The Integration of Healthcare in Dental Practice Conferences
DESCRIPTION:
URL:https://translationalresourcecenter.org/event/a-time-thats-come-the-integration-of-healthcare-in-dental-practice-conferences/
LOCATION:AZ
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211102T080000
DTEND;TZID=UTC:20211103T170000
DTSTAMP:20210824T192914Z
CREATED:20210824T192914Z
LAST-MODIFIED:20210824T192914Z
UID:2849-1635840000-1635958800@translationalresourcecenter.org
SUMMARY:Understanding the Role of the Immune System in Improving Tissue Regeneration: A Workshop
DESCRIPTION:The Forum on Regenerative Medicine will host a two-day workshop to explore potential promising approaches to modulate the immune system and/or the regenerative medicine product for improving the clinical outcomes of tissue repair and regeneration in patients. Discussions at the workshop may explore the current state of knowledge about immune tolerance mechanisms and lessons learned from other areas of research; advances in engineering of allogeneic donor cells for acceptance by the host’s immune system; effects of aging and other factors on the local environment\, endogenous repair\, and wound healing; modulating the host immune system to create a pro-regenerative environment; and developing tools and preclinical models for monitoring and optimizing the host’s pro-regenerative environment. \nRegister here.
URL:https://translationalresourcecenter.org/event/understanding-the-role-of-the-immune-system-in-improving-tissue-regeneration-a-workshop/
LOCATION:Virtual
CATEGORIES:Events
ORGANIZER;CN="The National Academies of Sciences%2C Engineering and Medicine":MAILTO:regenmed@nas.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211029T120000
DTEND;TZID=UTC:20211029T130000
DTSTAMP:20210924T194010Z
CREATED:20210924T194010Z
LAST-MODIFIED:20210924T194010Z
UID:2886-1635508800-1635512400@translationalresourcecenter.org
SUMMARY:USC/CHLA Cell Therapy Program Seminar Series: “The Clinical Translation of Cell and Gene Therapies: Q&A”
DESCRIPTION:USC/CHLA Cell Therapy Program Seminar Series\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegister\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n“The Clinical Translation of Cell and Gene Therapies: Q&A”\nOn Thursday\, October 29\, 2021 from 12-1pm Pacific Time (US and Canada) \nJoin us for a dialogue following a presentation by:\nMohamed Abou-el-Enein\, MD\, PhD\, MSPH\nAssociate Professor of Clinical Medicine\, Pediatrics\, and Stem Cell Biology & Regenerative Medicine\nExecutive Director\, Joint USC/CHLA Cell Therapy Program \nand \nMagdi Elsallab\, MD\nRegulatory Affairs and Clinical Development Specialist\, Joint USC/CHLA Cell Therapy Program\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJoin us and actively participate in the discussion! \n\nIdentifying an appropriate development strategy for cell therapy products\nOutlining expected evidence that should be collected on a cell therapy candidate to satisfy regulatory requirements\nAddressing frequent challenges facing investigators during the development of cell therapies\n\nRegister today!
URL:https://translationalresourcecenter.org/event/usc-chla-cell-therapy-program-seminar-series-the-clinical-translation-of-cell-and-gene-therapies-qa/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211027T113000
DTEND;TZID=UTC:20211027T123000
DTSTAMP:20211005T192824Z
CREATED:20211005T192824Z
LAST-MODIFIED:20211005T192824Z
UID:2915-1635334200-1635337800@translationalresourcecenter.org
SUMMARY:Bench2Market Talk - Topic: Translational Funding Opportunities Funding & Resources for Commercialization
DESCRIPTION:The next Bench2Market Talk topic on October 27th covers Translational Funding Opportunities and will include a panel of funders who will discuss their available resources for innovators and highlight what technology types and development stages are most appropriate for their funding opportunities. You can learn more about the speakers and register to attend for free at https://bit.ly/B2M_October2021 \nModerator:\nMike Cassidy\, MS\, Director\, Emory Biomedical Catalyst \nPanelists:\nAshley Cornelison\, Operations Director\, Venture Development at the Georgia Research Alliance\nCalvin Goforth\, PhD\, Chief Executive Officer of VIC Technology Venture Development\nCourtney Law\, PhD\, Managing Director\, Biolocity at Emory University and Georgia Tech
URL:https://translationalresourcecenter.org/event/bench2market-talk-topic-translational-funding-opportunities-funding-resources-for-commercialization/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211027T080000
DTEND;TZID=UTC:20211029T170000
DTSTAMP:20211006T233618Z
CREATED:20211006T233618Z
LAST-MODIFIED:20211006T233618Z
UID:2954-1635321600-1635526800@translationalresourcecenter.org
SUMMARY:International Society for Stem Cell Research and Japanese Society for Regenerative Medicine-Stem Cells: From Basic Science to Clinical Translation
DESCRIPTION:The International Society for Stem Cell Research (ISSCR) and the Japanese Society for Regenerative Medicine (JSRM) look forward to holding the International Symposium\, “Stem Cells: From Basic Science to Clinical Translation\,” from 27-29 October\, 2021 virtually. This exciting meeting will explore topics from stem cells in development to novel technologies in stem cell research and stem cell therapies. The meeting will also explore the ethical issues of stem cell biology and therapies through talks and a panel discussion. \nRegister here for this event. \nFull program can be seen here. \n*There is a cost to attend this event.  Go to the website for more information.*
URL:https://translationalresourcecenter.org/event/international-society-for-stem-cell-research-stem-cells-from-basic-science-to-clinical-translation/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211027
DTEND;VALUE=DATE:20211030
DTSTAMP:20211006T235537Z
CREATED:20211006T235537Z
LAST-MODIFIED:20211006T235537Z
UID:2956-1635292800-1635551999@translationalresourcecenter.org
SUMMARY:WORLD BIOPROCESSING SUMMIT: PHARMA 4.0
DESCRIPTION:THE WORLD SMART BIOPROCESSING: PHARMA 4.0 SUMMIT WILL GATHER WORLD TECHNOLOGY LEADERS FROM PHARMA\, BIOTECH\, AND PHARMA SUPPLIERS TO SHARE CASE STUDIES AND INTERACTIVE BREAKOUTS TOWARDS COMMERCIAL PROGRESS. \nToday’s Bioprocessing is the base of several emerging industries and technologies\, including the production of therapeutic stem cells\, gene therapy vectors\, and new vaccines. Advances in Bioprocessing is a particular interest to the industry as it considerably shortens the development timeline\, improves the final product and increase the productivity of Bio-manufacturing facilities. \nCparity’s World Smart Bioprocessing: Pharma 4.0 Summit is launching a world platform across the Pharma & Biopharmaceutical Manufacturing community to present their technological advances\, to boost innovation and exchange insights on current challenges. The event will gather top leaders in a 3-day event\, aiming to promote a high level participation to provide the appropriate environment for dialogue with peers from pharma\, biotech\, schools\, and pharma suppliers to maximize our efforts and profit in the industry. \nThis Summit program comprises complex case studies\, workshops\, panels and breakouts. It will combine forward-thinking leaders from different industries to discuss a range of topics on Bioprocessing and Smart manufacturing. We will approach main challenges\, innovations and new technologies. \nJoin our event to learn and get inspired from world leading industry experts and improve your business performance! \n\n\n\n\nConnect with global scientists\, engineers and executives working across the entire spectrum of biopharmaceutical development and production. \nTo register for this event\, go here. \nCheck out the website for more information on costs\, the agenda and the program.
URL:https://translationalresourcecenter.org/event/world-bioprocessing-summit-pharma-4-0/
LOCATION:InterContinental Berlin Hotel\, Budapester Strasse 2\, Berlin\, 10787\, Germany
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211026T150000
DTEND;TZID=UTC:20211027T170000
DTSTAMP:20211006T231020Z
CREATED:20211006T231020Z
LAST-MODIFIED:20211006T231020Z
UID:2952-1635260400-1635354000@translationalresourcecenter.org
SUMMARY:Global BioProcessing Summit
DESCRIPTION:Industry\, together with professionals and scientists are finding a way to map out some clearer directions and expectations about what is needed to improving the biopharmaceuticals processing systems. It is of paramount importance to companies to keep their production without disruption and hence accelerated\, optimized process from research to manufacturing is becoming critical. Global bioprocessing summit has come out as a leading forum for process development\, analytical and formulation scientists and industry experts to share day-to-day challenges and practical solutions for the development\, manufacture and quality of antibodies\, vaccines and gene therapies. Conferenzia World’s Global Bioprocessing Summit will provide a common platform for all stakeholders to build up a relationship and discuss on addressing global health manufacturing challenges\, optimizing technologies and strategies such as scaling up\, single-use technology\, digitalization and automation to accelerate bioprocessing. Join us to be a part of an interesting event with keynotes\, case studies\, fireside chats and panel discussion to gain valuable insights and thought-provoking inputs from experts. \nGo here\, to register for this event. \n*There is a cost to attend this event.  Please see the website for more information.*
URL:https://translationalresourcecenter.org/event/global-bioprocessing-summit/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211026T150000
DTEND;TZID=UTC:20211026T160000
DTSTAMP:20210917T175122Z
CREATED:20210917T175122Z
LAST-MODIFIED:20210917T175122Z
UID:2868-1635260400-1635264000@translationalresourcecenter.org
SUMMARY:DOCTRC Innovator Networking Series
DESCRIPTION:*Please see a link to the recording of this event below. \nRecording – https://www.dropbox.com/s/lci0op9z3g2eotp/10.26.2021_InnovatorSeries.mp4?dl=0 \nThe first DOCTRC Innovator Networking series will take place on Tuesday\, October 26\, 2021 at 3pm Eastern/12pm Pacific.  See below for webinar information. \n \n 
URL:https://translationalresourcecenter.org/event/doctrc-innovator-networking-series/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211026T110000
DTEND;TZID=UTC:20211026T120000
DTSTAMP:20211005T190207Z
CREATED:20211005T190207Z
LAST-MODIFIED:20211005T190207Z
UID:2911-1635246000-1635249600@translationalresourcecenter.org
SUMMARY:Materials Research Society Virtual Workshop Series - Biomaterials Science and Engineering to Address Unmet Needs in Women’s Health
DESCRIPTION:Women’s health continues to be an important and understudied area of research. Materials scientists and engineers have a long history of working with medical practitioners to solve problems related to human health and have the potential role to create solutions specific to women’s health issues. This MRS/SFB joint webinar aims to address recent materials developments in women’s health\, and the need for biomaterials approaches and collaborations in this broad area will be discussed. Specifically\, this joint webinar will provide an overview of opportunities for materials scientists and engineers to characterize materials\, design model tissue systems\, and apply computational methods in order to understand normal tissue as well as disease progression in women’s health. This includes topics such as biomaterials for replicating gynecological cancer\, biomaterials and computational modeling approaches for building placental models\, and biomaterials for building models of the endometrium. This perspective will encourage and inspire future researchers\, while engaging current researchers to think about redirecting their skills and efforts to addressing unmet needs in women’s health. Speakers will include: \n\n\n\nModerator: Joyce Wong\, Boston University\nKaitlin Fogg\, Oregon State University\nLinda Griffith\, Massachusetts Institute of Technology\nMichelle Oyen\, East Carolina University\n\n\n\nClick here to register. \n*There is a cost for this webinar.  Please see the registration site for more details.* 
URL:https://translationalresourcecenter.org/event/materials-research-society-virtual-workshop-series-biomaterials-science-and-engineering-to-address-unmet-needs-in-womens-health/
LOCATION:Virtual
CATEGORIES:Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211021T150000
DTEND;TZID=UTC:20211021T163000
DTSTAMP:20211018T200201Z
CREATED:20211018T200201Z
LAST-MODIFIED:20211018T200201Z
UID:2974-1634828400-1634833800@translationalresourcecenter.org
SUMMARY:The Forsyth Institute presents: Only Orphans COTE - Delivering Drugs through the FDA and EMA
DESCRIPTION:Interested in drug development?\nLearn the “unwritten rules” of FDA submissions\, regulatory meetings and special programs from Dr. Timothy Cote\, MD\, MPH\, the newly-arrived Entrepreneur-in-Residence at the Forsyth Institute. \nAbout this event\n\n\nGot an idea for a new drug for a wicked rare disease? How do you move from idea to fantasy to pharmacy? More specifically\, who are those people at the FDA and how can you best engage with them without losing momentum? \nTimothy Cote MD MPH is the newly-arrived Entrepreneur-in-residence at the Forsyth Institute\, based in Cambridge MA. He will be hosting a monthly in vivo cum in silico seminar series to discuss topics in orphan drug development with an emphasis on regulatory affairs in the US and Europe. With more than 15 years of experience in the field\, Dr. Cote was previously the Director of FDA’s Office of Orphan Products Development. In that capacity he personally signed 1\,400 orphan drug designation decisions and saw 140 orphan drugs go to full marketing authorization. \nDr. Cote will be hosting a new monthly seminar series to discuss topics in orphan drug development with an emphasis on regulatory affairs in the US and Europe. \nDate and time: Thursday\, October 21\, 2021 \n3:00 PM – 4:30 PM Eastern \nZoom link provided upon registration. \nFDA has some special perks of extraordinary value. Learn how you qualify\, what they give you and how to apply. \n\n\nRegister for this event. Registration is Free.
URL:https://translationalresourcecenter.org/event/the-forsyth-institute-presents-only-orphans-cote-delivering-drugs-through-the-fda-and-ema/
LOCATION:The Forsyth Institute\, 245 First Street\, Cambridge MA\, 02142\, MA\, 02142\, United States
CATEGORIES:Events
ORGANIZER;CN="The Forsyth Institute":MAILTO:anicodemo@forsyth.org
END:VEVENT
END:VCALENDAR